EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Synthesis and evaluation of multitarget new 2‐aminothiazole derivatives as potential anti‐Alzheimer's agents

Merve Bardakkaya, Burcu Kilic, Rahsan Ilıkcı Sagkan iD, Fatma Aksakal, Shakila Shakila iD, Deniz S Dogruer

Archiv der Pharmazie · 2023-08 · 356 (8)

DOI: 10.1002/ardp.202300054 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archiv der Pharmazie, online erschienen am 05.06.2023. Verfasst von Merve Bardakkaya und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Gazi University, Ankara, Turkiye. Hauptthemen laut MEDLINE: Alzheimer Disease, Neuroprotective Agents. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Türkiye Bilimsel ve Teknolojik Arastirma Kurumu.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this study, two diverse series of 2‐aminothiazole‐based multitarget compounds, one propenamide and the other propanamide derivatives, were designed and synthesized. Subsequently, their anticholinesterease and antioxidant (ORAC) activities were tested. Among them, compound 3e was the most potent acetylcholinesterase (AChE) inhibitor (AChE IC 50 = 0.5 μM, butyrylcholinesterase [BChE] IC 50 = 14.7 μM) and compound 9e was the most potent BChE inhibitor (AChE IC 50 = 3.13 μM, BChE IC 50 = 0.9 μM). Kinetic experiments showed that both compounds were mixed‐type inhibitors. According to the anticholinesterease activity results, five compounds ( 3e , 4e , 5e , 9d , and 9e ) were selected for further activity studies, all of which are dual cholinesterase inhibitors. Then, selected compounds were investigated in terms of their metal chelation activity. Moreover, their neuroprotective effects against H 2 O 2 ‐induced damage in the PC12 cell line were evaluated at 10 μM and the results showed that the neuroprotective effect of 3e was 53% compared with the reference ferulic acid (77%). 3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyltetrazolium bromide (MTT) results of selected compounds revealed that the compounds were noncytotoxic. Additionally, 3e was more effective in reducing lipopolysaccharides‐induced interleukin‐1β (IL‐1β), IL‐6, tumor necrosis factor‐α (TNF‐α), and nitric oxide (NO) production in the human monocyte derived from patient with acute monocytic leukemia cell line compared with other selected compounds. Finally, a molecular docking study was also performed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseNeuroprotective AgentsHumansButyrylcholinesteraseAcetylcholinesteraseMolecular Docking SimulationStructure-Activity RelationshipCholinesterase InhibitorsThiazoles

Stichwörter der Autor:innen

2-aminothiazoleAlzheimer's diseaseanti-inflammatorycholinesterase inhibitory activityneuroprotective effect

Substanzen

ButyrylcholinesteraseAcetylcholinesteraseCholinesterase InhibitorsNeuroprotective Agents2-aminothiazoleThiazoles

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Gazi University, Ankara, Turkiye.
  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Biruni University, İstanbul, Turkiye.
  • Department of Medical Biology, Faculty of Medicine, Uşak University, Uşak, Turkiye.
  • Department of Chemistry, Faculty of Science, Hacettepe University, Ankara, Turkiye.
  • Department of Analytical Chemistry, Faculty of Pharmacy, Kocaeli Health and Technology University, Kocaeli, Turkiye.

ORCID-Profile: Rahsan Ilıkcı Sagkan, Shakila Shakila

Förderung

  • Türkiye Bilimsel ve Teknolojik Arastirma Kurumu

Zitieren

APA

Bardakkaya, M., Kilic, B., Sagkan, R. I., Aksakal, F., Shakila, S., & Dogruer, D. S. (2023). Synthesis and evaluation of multitarget new 2‐aminothiazole derivatives as potential anti‐Alzheimer's agents. Archiv der Pharmazie, 356(8). https://doi.org/10.1002/ardp.202300054

Vancouver

Bardakkaya M, Kilic B, Sagkan RI, Aksakal F, Shakila S, Dogruer DS. Synthesis and evaluation of multitarget new 2‐aminothiazole derivatives as potential anti‐Alzheimer's agents. Archiv der Pharmazie. 2023;356(8). doi:10.1002/ardp.202300054

BibTeX
@article{Bardakkaya2023,
  author = {Bardakkaya, Merve and Kilic, Burcu and Sagkan, Rahsan Ilıkcı and Aksakal, Fatma and Shakila, Shakila and Dogruer, Deniz S},
  title = {Synthesis and evaluation of multitarget new 2‐aminothiazole derivatives as potential anti‐Alzheimer's agents},
  journal = {Archiv der Pharmazie},
  year = {2023},
  volume = {356},
  number = {8},
  doi = {10.1002/ardp.202300054}
}
Kostenlos starten →